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Abstract
The Receptor for Activated C Kinase 1 (RACK1) is a member of the tryptophan-aspartate repeat (WD-repeat) family
of proteins and shares significant homology to the b subunit of G-proteins (Gb). RACK1 adopts a seven-bladed b-
propeller structure which facilitates protein binding. RACK1 has a significant role to play in shuttling proteins
around the cell, anchoring proteins at particular locations and in stabilising protein activity. It interacts with the
ribosomal machinery, with several cell surface receptors and with proteins in the nucleus. As a result, RACK1 is a
key mediator of various pathways and contributes to numerous aspects of cellular function. Here, we discuss
RACK1 gene and structure and its role in specific signaling pathways, and address how posttranslational
modifications facilitate subcellular location and translocation of RACK1. This review condenses several recent
studies suggesting a role for RACK1 in physiological processes such as development, cell migration, central nervous
system (CN) function and circadian rhythm as well as reviewing the role of RACK1 in disease.
Keywords: RACK1, WD-repeat, guanine nucleotide binding protein 2-like 1, (Gβ), heterotrimeric G-proteins, PKCβII,
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Introduction
The WD-repeat family of proteins
The tryptophan, aspartic acid repeat (WD-repeat con-
taining proteins are an ancient conservative family of
proteins found in prokaryotes and all eukaryotes [1].
They are involved in almost every signaling pathway and
are associated with many genetic diseases. To date over
100 WD-repeat proteins have been assigned with an
approved name and designation in the human nomen-
clature database. Genes encoding WD-repeat proteins
are found on all chromosomes except 20, 22 (a pseudo-
gene FBXW4P1 has been reported in chromosome 22),
and the Y chromosome http://www.genenames.org This
reflects their diversity and importance as a family, and
suggests that their expression is regulated by a variety of
signaling pathways. WD-repeats themselves are
sequences of typically 44-60 amino acids in length end-
ing at the C-terminus with a signature WD dipeptide or
its equivalent (Figure 1). The motifs were first identified
as repeating segments of homologous sequence within
the primary structure of the transducin Gb subunit and
CDC4 [2]. Detailed analysis with a larger cohort of pro-
teins revealed that the repeats are also typified by a
characteristic GH dipeptide usually residing some 11-24
residues from the N-terminus, though neither the GH
nor WD signature is absolutely conserved [3-5]. Several
other characteristic amino acids contribute to the repeat,
most notably an aspartic acid located 6 residues before
the WD dipetide, but it is the collective critical mass of
such features rather than the absolute conservation of
any individual amino acid that establishes the identity of
a sequence as a WD-repeat [6]. Given the variable num-
ber of residues at the N-terminal end of these units,
sequence databases tend to map the repeats of WD-pro-
teins between GH and WD dipeptides for convenience
(Figure 1). The basic criterion for inclusion of a protein
into the family is the presence of at least four of these
repeat sequences to generate a WD-domain. These
domains adopt a b-propeller structure, where the pro-
peller fold is characterised by blades that are arranged
radially around a central axis [3,7-10] (Figure 2). The
conserved propeller structure is maintained by well-
defined hydrogen bonding networks and intra-chain
hydrophobic interactions (vide infra), although different
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WD-repeat proteins appear to adopt distinct folding
orders for their constituent propeller blades [9,11]. In
principle, a single b-propeller subunit may comprise
four to eight blades [4,8], although at present only 7-
bladed or 8-bladed WD-repeat propellers have been
characterised by X-ray diffraction studies-the majority
being 7-bladed structures consistent with the proposal
that this is the optimal b-propeller fold [12]. Proteins
are known with more than eight WD-repeats, but these
assume tertiary structures with multiple propeller subu-
nits (reviewed in [6]).
Although there is no single function for WD-repeat
proteins, they share a common role in scaffolding pro-
tein complexes, often with multiple and competing part-
ners, thereby serving as hubs for spatiotemporal
orchestration of signaling events across diverse path-
ways. WD-repeat proteins themselves lack any enzy-
matic activity, but they are subject to post-translational
modification, suggesting ways by which their cellular
location and protein partnerships may be modulated.
The lack of a direct catalytic enzymatic function for the
protein family contrasts with other b-propeller-forming
proteins, many of which exhibit enzymatic activity [8].
The most exstensively studied WD-repeat protein to
date is the G-protein b subunit (Gb) [7,13], which exists
in a complex with the g subunit (Gg). Gbg reversibly
complexes with the a subunit to form a Gabg hetero-
mer that associates with G-protein-coupled receptors
(GPCRs) to enable transduction of extracellular signals.
Upon ligand binding to a GPCR, the a subunit dissoci-
ates from the Gbg heterodimer, resulting in the activa-
tion of various signaling cascades (reviewed in [14,15]).
The mode of interaction of Gb with binding partners
has become increasingly clear with the emergence of
crystal structures for Gb in various complexes with Ga/
Gg, [9,10,16,17], phosducin [18-20], GPCR Receptor
Kinase 2 (GRK2) [21-23], Regulator of G-protein Signal-
ing 9 (RGS9) [24,25], and the Parathyroid Hormone 1
Receptor (PTH1R) [26]. Interestingly, WD-domains do
not operate simply as standalone platforms for scaffold-
ing protein complexes. Thus, several WD-proteins
including RACK1 form both homodimers and
heterodimers [27-29]. Moreover, some WD-repeat pro-
teins contain other domains in addition to the WD-
repeat sequences that increase the number of binding
partners, scaffolding properties and overall function of
the protein. For example, the b-transducing repeat-con-
taining protein 1 (b-TrCP1) is a ubiquitin ligase with
both WD-repeat and F-box domains as well as a RING
domain. b-TrCP1 is required for the degradation of reg-
ulatory proteins such as Snail and p53 [30,31], and the
WD-repeats increase its binding cohort and regulate its
sub-cellular location, allowing the protein to also have a
role in transcription and in regulating circadian rhythm
[32-34]. WD-repeat and (suppressor of cytokines signal-
ing) SOCS box-containing protein 1 (WSB1) is a ubiqui-
tin ligase subunit, induced by Hedgehog signaling, that
contains in addition to its WD-domain a SOCS-box that
mediates its interaction with a ubiquitinating catalytic
core complex [35,36]. WSB1 promotes cell survival in
neuroblastoma [37]. Novel Nuclear Receptor Interaction
Protein (NRIP) is a nuclear receptor with two WD-
repeat domains which also has a nuclear localization sig-
nal [38]. NRIP interacts with the androgen receptor [39]
and has recently been implicated in viral replication
[40].
As our knowledge of the WD-repeat family of proteins
expands, we are seeing that the members are involved in
most signaling pathways (reviewed in [1]). It is no sur-
prise, therefore, that WD-repeat proteins play a critical
role in various human diseases. Subtle changes in the
expression levels of WD-proteins can have a dramatic
effect on protein complex assembly and on key signaling
pathways. In this review, we focus on RACK1, a 36-kDa
protein with seven WD-repeats that is homologous to
Gb, and that is one of the best known and studied
members of the WD-repeat protein family. We focus on
its structure, binding partners, subcellular localization,
its role in signaling pathways and its function in normal
physiological responses as well as in pathological
conditions.
RACK1 is a scaffolding protein
RACK1 is a highly conserved intracellular adaptor pro-
tein with significant homology to Gb. RACK1 was ori-
ginally cloned from a chicken liver cDNA library and
human B-lymphoblastoid cell line (B-LCL) [41]. Several
years later, Mochly-Rosen’s group cloned the protein
from a rat brain c-DNA library which was screened for
gene products that bind purified rat brain PKC in the
presence of its activators (phosphatidylserine, diacygly-
cerol and calcium) [42]. Given the association of
RACK1 with the active conformation of PKCbII, the
protein was named Receptor for Activated C Kinase 1
(RACK1) [42-45] (Figure 3). However, it is now well
established that RACK1 interacts with a large number of
MTEQMTLRGTLKGHNGWVTQIATTPQFPDMILSASRDKTIIMWKLTRD
ETNYGIPQRALRGHSHFVSDVVISSDGQFALSGSWDGTLRLWDLTTG
TTTRRFVGHTKDVLSVAFSSDNRQIVSGSRDKTIKLWNTLGVC
KYTVQDESHSEWVSCVRFSPNSSNPIIVSCGWDKLVKVWNLANCKLK
TNHIGHTGYLNTVTVSPDGSLCASGGKDGQAMLWDLNEG
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Figure 1 Sequence of RACK1 depicting WD-repeats. RACK1 is a
317 amino acid protein with seven 40 amino acid repeats which
are defined by sequences flanked by GH and WD dipeptides.
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Figure 2 Structural detail for RACK1 proteins. (A) Crystal structure of RACK1A from A. thaliana (PDB: 3DM0), illustrating the seven-bladed b-
propeller structure. (B) As (A) but with surface rendition. (C) Schematic representation of RACK1 structure and organisation of WD-repeats
(defined in Figure 6); peripheral circles show superimposition of individual propeller blades for Gb1 (blue) (PDB: 1TBG) and for the structurally
defined RACK1 orthologues from A. thaliana (green) (PDB: 3DM0), S. cerevisiae (orange) (PDB: 3FRX) and T. thermophila (pink) (PDB: 2XZN). Gb is
distinguished in blade 7 by a helical N-terminal extension that engages tightly bound Gg (not shown) in coiled coil interactions.
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proteins either directly or as part of a larger complex.
As a scaffold protein, RACK1 integrates inputs from dis-
tinct signaling pathways and is critical for fundamental
cellular activities such as cell proliferation, transcription
and protein synthesis, as well as various neuronal func-
tions. RACK1’s scaffolding properties are mediated by
the presence of seven WD-repeats [46,47] (see also sec-
tions 2.2 and 2.3) that present multiple protein-binding
sites and facilitate interaction with specialized protein
docking modules, including SH2 domains (Src and Fyn)
[48,49], plextrin homology (PH) domains (dynamin and
p120GAP) [50,51] and C2 domains (PKCs) [43,45]. In
addition, RACK1 was pulled out in a yeast two-hybrid
screen as a binding partner of the first PDZ domain of
the human Na+/H+ exchanger regulatory factor
(NHERF1) [52]. RACK1 also forms a heterodimer with
at least one other WD-repeat protein, Gb [27,28,53].
The formation of the RACK1-Gb heterodimer has been
shown to enable efficient cross-talk between signal
transduction pathways mediated by GPCRs and by
ligand-gated ion channels, specifically between the
cAMP/PKA pathway and the N-methyl D-aspartate
receptor (NMDAR) [29] (Figures 4 and 5). RACK1 also
functions as a homodimer enabling the expansion of its
binding partners [28,29,49,53,54]. For example, the for-
mation of a homodimer enables the simultaneous inter-
action of RACK1 with Fyn and with the NR2B subunit
of the NMDAR, even though Fyn and NR2B share the
same binding site on RACK1 [29,49,55-57] (Figure 5A).
The proteins interacting with RACK1 fall into two
broad categories, those constitutively bound and those
that are stimulus-dependent or transient. RACK1
R
RACK1 InactivePKCβII
Substrate
A
R
L
B
Substrate
RACK1RACK1
Figure 3 Model for PKCbII and RACK1 interaction. (A). In resting
state, there is no interaction between RACK1 and inactive PKCbII.
(B). Activation of PKCbII leads to the interaction between the active
form of the kinase and RACK1. RACK1 then shuttles the active
PKCbII to the site of its substrate.
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Figure 4 Model for cAMP/PKA-mediated nuclear translocation
of RACK1. (A). In resting state, RACK1 forms homodimers as well as
heterodimers with Gb. (B). Activation of the cAMP/PKA pathway
leads to the dissociation of RACK1 from the complex and its
translocation to the nucleus. In the nucleus RACK1 contributes to
cAMP/PKA mediated increase in BDNF transcription.
Adams et al. Cell Communication and Signaling 2011, 9:22
http://www.biosignaling.com/content/9/1/22
Page 4 of 24
binding partners have been identified at various loca-
tions throughout the cell, and one important functional
role for RACK1 is undoubtedly to shuttle some of these
binding partners to particular intracellular sites. How-
ever, in addition to this role, a key aspect of the func-
tion of RACK1 is its capacity to modulate the enzymatic
activity of its binding partners, either promoting or sup-
pressing the activity of bound enzymes. For example,
RACK1 stabilizes the activity of protein phosphatase 2A
(PP2A) [58,59] and maintains the active conformation of
PKCbII [42,45,60] (Figure 3). In contrast, RACK1 binds
to the tyrosine kinases Src and Fyn to maintain these
kinases in an inactive state until the appropriate signal
occurs to trigger dissociation of the complex
[29,49,55-57,61,62] (see also Figure 5A). Thus, RACK1
plays a key role in stabilizing the active or inactive con-
formation of its partners.
RACK1, Gene and Structure
RACK1: Gene, promoter and expression
Human RACK1 is encoded by the gene, GNB2L1 [gua-
nine nucleotide binding protein (G-protein), beta poly-
peptide 2-like 1], which has 8 exons and 7 introns
[63,64]. The open reading frame of the gene is 1142 bp
and it encodes for a protein with 317 amino acids, regis-
tering as a 36 kDa protein on an SDS PAGE gel. Studies
probing the evolution of human RACK1 suggest that
human, rat and mouse RACK1 form a different sub-
group and are therefore strictly paralogs of RACK1 in
other organisms, but these studies nevertheless indicate
that RACK1 is strongly conserved through evolution
[64]. Indeed, sequence alignments of RACK1 species
from diverse organisms – Tetrahymena thermophila,
Saccharomyces cerevisiae, Arabidopsis thaliana and Dro-
sophila melanogaster – reveals a 43-76% sequence iden-
tity (Figure 6). GNB2L1 is mapped to chromosome
5q35.3, in close proximity to the telomere of chromo-
some 5 [63]. At least 6 other genes have been mapped
to this region and it is a reported location for cytoge-
netic and molecular abnormalities [65-68]. The promo-
ter region of GNB2L1, which was found to have two
alternative start sites of transcription, has binding sites
for cardiac/smooth muscle specific c-Rel (NF-B)
[63,69]. RACK1 is highly expressed in most tissues [70],
including the brain [71]. The expression of RACK1
appears to be tightly regulated and changes in RACK1
NR2B
RACK1
NR1
Fyn
cAMP/PKA
B
C
RACK1
Fyn
NR2BNR1
RACK1 Fyn
NR2BNR1
D
A
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NR2BNR1
RACK1
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Figure 5 Differential compartmentalization of RACK1 in the
brain. (A). In hippocampal and dorsal striatal neurons, RACK1 is
associated with both the NR2B subunit of the NMDAR and Fyn
kinase. (B). cAMP/PKA activation or alcohol exposure leads to the
release of RACK1 from the complex, enabling Fyn to phoshorylate
the tyrosine residues on the cytoplasmic tail of the NR2B. (C). In the
cerebral cortex, RACK1 is bound to Fyn but not to the NMDAR. (D).
In the ventral striatum, RACK1 is not associated with either protein.
Figure 6 Sequence alignment of Gb1 (UniProtKB accession ID:
P62873) vs RACK1 orthologues from Homo sapiens (P63244),
Drosophila melanogaster (O18640), Arabidopsis thaliana
(O24456), Saccharomyces cerevisiae (P38011) and Tetrahymena
thermophila (E6PBV0). This alignment is similar to that presented
by Ullah et al [81] but revised to include the sequence of the T.
thermophila protein. WD-repeats and secondary structural elements
are defined above the sequences. The percentage sequence identity
between human RACK1 and the orthologues from other species is
defined at the end of the alignment. The homology index for the
proteins (excluding Gb1) is presented below the sequence, where
fully conserved residues are marked with an asterisk; conservative
and semiconservative positions are marked with colons and periods
respectively. Residues marked in red in the yeast sequence engage
rRNA in the eukaryotic 40S ribosomal subunit (see text).
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expression are associated with cancer (see section 6.1.).
It has also been suggested that changes in RACK1
expression contribute to brain pathologies [72-74] (see
section 6.2.). This is supported by observations from our
group and others that RACK1 is inhibitory to the
growth of normal fibroblasts and can only be over-
expressed in transformed cells or cells that over-express
the IGF-1R [75-77]. Interestingly, a binding site for the
glucocorticoid receptor is present in the GNB2L1 pro-
moter [63], suggesting a mechanism by which RACK1
expression levels may change with aging. This is signifi-
cant given that RACK1 affects the subcellular distribu-
tion and function of numerous proteins and, as a result,
plays an essential role in regulating signaling pathways
in many key biological processes [46,47]. Indeed, over
80 binding partners of RACK1 have been reported to
date, (although several of these remain uncharacterised
and may not bind to RACK1 directly), and as new part-
ner proteins emerge, the important contribution that
RACK1 makes to signaling pathways is becoming
clearer. It is probable that RACK1 engages in different
sets of signaling pathways in different cells, reflecting
the cell type and the differential expression of its bind-
ing partners. In this way, RACK1 plays distinct roles in
different cell types, even when the expression of RACK1
itself remains relatively constant.
Structure of RACK1
Gb was the first WD-repeat protein to be characterised by
X-ray crystallography [9,10,16]. Numerous crystal struc-
tures have since emerged for WD-repeat proteins [9,10,78]
and these now include recently determined structures for
three RACK1 species: RACK1A from A. thaliana, Asc1p
from S. cerevisiae and RACK1 from T. thermophila at 2.4,
2.1 and 3.9 Å resolution, respectively [79-82]. The T. ther-
mophila protein structure was obtained as a complex with
the 40S small ribosomal subunit from this protozoan. A
structure for the yeast RACK1 orthologue was also deter-
mined in complex with the 40S ribosomal subunit at simi-
lar resolution (4.15 Å) [83]. These structural studies
confirmed that RACK1 adopts a seven-bladed b-propeller
structure consistent with the predictions of earlier homol-
ogy modelling studies based on Gb and other WD-repeat
proteins [46,78-81]. The A. thaliana protein was the first
of the three RACK1 orthologues to be structurally defined
and, of the three, it exhibits the highest sequence homol-
ogy to human RACK1, with 64% residue identity [81] (Fig-
ure 6). In contrast to metazoans, where RACK1 is
expressed from a single gene, A. thaliana possesses three
genes-RACK1A, RACK1B and RACK1C - for closely
related proteins, with the sequences for RACK1B and
RACK1C (not shown) exhibiting similar levels of homol-
ogy to the human protein. The structure of RACK1A is
shown in Figure 2A. Each propeller blade consists of a
four-stranded antiparallel b-sheet, where strand A lines
the central canal of the protein, a channel of ~9 Å width
(Figure 2B), and strand D is presented on the outer cir-
cumference. Adjacent blades are connected by a loop brid-
ging from strand D on one blade to strand A on the next.
These loops are exposed on the top face of the propeller
blade, as are the b-turns linking strands B and C in each
blade. The loops connecting strand A to B and strand C to
D in each blade are located on the reverse, slightly larger
face of the propeller.
The WD-repeats of RACK1, as with all proteins that
adopt this fold, overlap two adjacent propeller blades to
provide an interlocking architecture. Each repeat encom-
passes the D-strand of one blade and strands A, B and C
of the next, terminating in the signature WD dipeptide at
the end of strand C such that the aspartic acid (or equiva-
lent residue) is exposed on the propeller’s lower face. The
tryptophan, which is sometimes replaced by phenylalanine
or tyrosine, is sandwiched between adjacent blades and
plays an important role in inter-blade spacing (Figures 2
and 6). As the N-terminal sequence in the first WD-repeat
contributes strand D of the seventh blade, hydrogen bond-
ing to the strand C sequence of the last repeat, the assem-
bly is sealed with a ‘Velcro-like’ fastening to complete the
toroidal structure [5]. Superimposition of the available
RACK1 crystal structures with human Gb1, shown for
individual propeller blades in Figure 2C, reveals that the
greatest structural variation lies in the A-B, C-D and D-A
loops, which are of variable length. Most notably, the D-A
loop between blades 6 and 7 in the RACK1 species is 8-19
residues longer than the cognate region of Gb1 and forms
a pronounced knob-like projection from the upper face of
the propeller (disordered in the crystal structure of A.
thaliana RACK1A). In contrast to the three other loops,
the central B-C hairpin of each blade adopts a tight b-turn
with a strongly conserved backbone conformation. Some
85% of known WD-repeats possess an aspartic acid at the
middle position of the three residues usually present in the
B-C turn [11], and this highly conserved residue forms a
salt bridge with the histidine of the glycine-histidine (GH)
signature dipeptide (when present) as shown in Figure 7.
This GH interaction plays an important role in defining
the trajectory of the inter-blade D-A loop which hosts the
GH dipeptide and therefore in stabilising the propeller
structure. A network of additional hydrogen bonded inter-
actions between strongly conserved residues at specific
locations within the WD-repeat also maintains the integ-
rity of blade structure. Thus, the histidine of the GH
dipeptide is characteristically hydrogen bonded to a serine
(or threonine) on b-strand B located in the P-4 position
relative to the conserved aspartic acid (P-0) of the B-C
turn. This serine is usually hydrogen bonded in turn to the
indolic NH of the WD signature tryptophan (occupying
the P+6 position). The structure of the B-C turn is
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additionally defined by an engagement between the P-0
aspartate side chain and the peptide backbone NH at the
P+2 position (i.e. the first amino acid in b-strand C). The
final residue in b-strand B (at the P-2 position) is invari-
ably small (Ser, Gly or Ala) for typical blades1 in order to
accommodate the folding of the aspartic acid side chain.
In the majority of instances the P-2 residue is serine, and
in these cases the residue also engages the aspartate with a
hydrogen bond to strengthen the local structure of the
protein in that region. Non-polar interactions also play an
important role in establishing the b-propeller structure
however. For example, the opening residue in b-strand A
that lies proximal to the B-C turn is almost invariably
valine or isoleucine and fits into the space between the B-
and C-strands of the preceding propeller blade, directly
behind the P-0 aspartic acid of the B-C turn on that blade
and regulating inter-blade spacing at that point. The WD
signature tryptophan (or phenylalanine/tyrosine replace-
ment) projects from the face of each propeller blade to
pack against a bulky residue (frequently leucine) located at
the end of the D-strand and projecting from the rear of
the preceding blade.
The features described above and summarised in Fig-
ure 7 are tightly conserved across blades 1-5 of the
RACK1 proteins and are responsible for a highly regular
and ‘typical’ organisation to the core of the propeller
blades for this major segment of the proteins. Some
notable deviations are seen in the core organisational
elements for blades 6 and 7, however, and these are
likely associated with the RACK1 sequence insert in the
D-A loop between these two blades. This loop lacks the
characteristic GH signature dipeptide to engage the con-
served Asp of the B-C turn in blade 7. Instead, an Arg
on b-strand C of blade 7 provides a surrogate salt bridge
in lieu of the signature GH to stabilise the blade 7 B-C
hairpin. This is illustrated in Figure 8 with the yeast
RACK1 orthologue, where the D-A loop between blades
6 and 7 is of similar length to human RACK1 and fully
ordered in the crystal structure. The cognate loop of
Figure 7 Summary of conserved interactions in ‘typical’ WD-
repeats responsible for maintaining the structural integrity of
propeller blades 1-5 in RACK1. Interactions are illustrated for
blade 2 of the A. thaliana RACK1A structure (PDB: 3DM0). The
second WD-repeat (as defined in Figure 6) is shown in its entirety
(orange ribbon) and contributes b-strand D to blade 1 plus strands
A, B and C of blade 2, terminating in the WD signature residues
(W90-D91). Strand D of blade 2 is provided by residues in the third
WD repeat (yellow ribbon). A highly conserved Asp residue (D84)
occupies the central position of the B-C turn and is networked by
hydrogen bonds to residues in the P-2 and P+2 positions (S82 side
chain, E86 backbone) as well as through a salt bridge to the
signature GH His (H62) in the D-A loop between blades 1 and 2.
H62 is further networked with a hydrogen bond to S80 on b-strand
B and a hydrogen bond between S80 and W90 (b-strand C).
Important non-polar interactions regulate blade packing such as
contact between W90 and residues on the reverse face of blade 1
(L59) and between V66 (b-strand A) and the reverse face of the B-C
hairpin of blade 1 (not shown). B-C hairpin positions relative to the
consensus Asp (P0) are marked in blue.
Figure 8 Summary of key interactions in ‘atypical’ WD-repeats
6 and 7 of RACK1, illustrated with the structure of yeast Asc1p
(PDB: 3FRX). RACK1 proteins are characterised by a significant
sequence extension between blades 6 and 7, leading to a knob-like
protrusion from the upper face of the propeller. The P0 Asp in
blade 7 forms a salt bridge to an Arg at the P+4 position and this is
packed against a Tyr (or in some orthologues Phe) in the P-2
position. The P0 Asp is absent in blade 6. In principle, these features
together with the absence of the GH signature dipeptide on the
loops between blades 5 and 6 and between blades 6 and 7 may
facilitate structural transitions in this region of the protein that are
important for function.
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RACK1 proteins in plants, as with A. thaliana, is signifi-
cantly extended by comparison. The arginine residue
(R311) that contributes the salt bridge to the B-C hair-
pin of blade 7 lies in the P+4 position relative to the
aspartic acid (D307) and is packed against a tyrosine
side chain (Y305) in the P-2 position of this atypical
WD-repeat. In contrast, as noted above, the P-2 position
is taken by Ser or Gly in typical WD-repeats (Figure 7).
In blade 7 this rare occurrence of a Tyr is associated
with the establishment of pi-cation interactions with the
P+4 Arg (Figure 8). Significantly, the tyrosine is con-
served across RACK1 orthologues of higher organisms
and is a known phosphorylation site (vide infra) [58],
suggesting a functionally important role for the atypical
structure of this RACK1 WD-repeat. Indeed, the scaf-
folding of several proteins is known to be mediated by
blades 5-7 of RACK1.
The D-A and B-C loops of WD-repeat proteins alter-
nate with one another in sequence to generate the
upper face of their b-propeller structures (as presented
in Figure 2). Thus, the extended D-A loop that forms
the RACK1 knob between blades 6 and 7 is followed by
the B-C hairpin on blade 7 and preceded by the corre-
sponding hairpin on blade 6. Given the atypical features
just described in the B-C hairpin of blade 7, it is unsur-
prising that the corresponding hairpin of blade 6, imme-
diately preceding the knob, should also differ from the
typical consensus features summarised in Figure 7. The
key distinction in this hairpin is the deletion of the cen-
tral aspartic acid residue of the b-turn, and a very tight
turn of two residues serves to reverse the backbone
between b-strands B and C in blade 6, though neither of
the residues at this site is conserved across RACK1
orthologues (Figure 6). In the yeast structure, the turn
comprises A257 and T258 (Figure 8). Deletion of the
aspartic acid from the B-C turn also appears to be asso-
ciated with loss of the signature GH dipeptide from the
preceding D-A loop between blades 5 and 6, where, in a
typical WD-repeat, the histidine would engage the
aspartic acid of the B-C turn. Thus, RACK1 proteins
lack the GH motif in the D-A loops between both
blades 5/6 and blades 6/7. Significantly, the absence of
the GH in these loops appears to make the presence of
the consensus P-4 serine on b-strand B redundant in
blades 6 and 7, and the serine is replaced by alanine in
both blades of yeast and mammalian RACK1 proteins.
As shown in Figure 7, the P-4 serine hydrogen bonds to
the preceding GH signature histidine in typical WD-
repeats. Substitution of the P-4 serine by alanine has a
further effect, however, and abolishes the additional
hydrogen bond to the WD signature tryptophan that is
seen in typical WD-repeats. The abolition of this hydro-
gen bond appears to be associated with a change in the
conformation of the tryptophan side chain in blade 7 of
the yeast protein, where the indolic NH is no longer
constrained in a hydrogen bond towards strand B but
re-orientated towards strand D instead. Interestingly, in
blade 6 of the yeast structure, the WD tryptophan is
replaced by phenylalanine, and it is conceivable that
where the P-4 serine of the B-strand is substituted by a
non-hydrogen bonding residue evolutionary conserva-
tion of the signature tryptophan is also relaxed.
Structural basis for RACK1-scaffolded protein associations
The available crystal structures for Gb and other WD-
repeat proteins have established the structural basis for
scaffolded interactions with a range of partner proteins-
Ga/Gg, phosducin, GRK2, RGS9 and PTH1R in the case
of Gb for example (vide supra)-and the current under-
standing of WD-repeat protein docking modes has
recently been reviewed in detail [6]. Unfortunately,
structural information relating specifically to the interac-
tions of RACK1 with its numerous protein partners cur-
rently remains very limited.
Scanning peptide arrays, mutagenesis studies and
competition experiments with RACK1-derived peptides
have identified probable loci on the surface of RACK1
that may contribute to protein-protein interfaces for
some of RACK1’s partners. The most detailed informa-
tion relating to RACK1-biomolecule associations cur-
rently available, however, has emerged from structural
studies with ribosomes. Initial breakthroughs came with
the use of cryoelectron microscopy (cryo-EM) techni-
ques, affording a low resolution (11.7 Å) structure for
the yeast 40S ribosomal subunit that identified the posi-
tion of bound RACK1 on the head region proximal to
the mRNA exit channel [84]. The cryo-EM map of a
mammalian 40S subunit followed at slightly higher reso-
lution (8.7 Å) [85]. These studies pre-dated the RACK1
X-ray crystal structures, and the ribosome structure was
constructed by fitting homology models of individual
ribosomal components (templated on Gb in the case of
RACK1) to the cryo-EM map. Both models implicated
helices 39 and 40 of the 18S ribosomal RNA as the pri-
mary anchoring region for RACK1, with contact
mediated largely by blades 1 and 2 and their associated
loops. Consistent with this, binding of RACK1 to ribo-
somes is compromised by mutation of a number of
basic residues that are conserved across the identified
RNA binding interface of RACK1 species but that are
absent at the cognate sites in Gb (Figure 6). Thus, a
double charge reversal mutation (R38D:K40E) in the
RDK B-C turn of blade 1 almost fully ablates binding of
the yeast protein (Asc1p) to the ribosome [79,84]. Ala-
nine mutations for K87, R90 and R102, residues that
project from the B-C turn and edge of blade 2 in Asc1p,
also attenuate binding to the ribosome [79]. Similarly,
alanine mutagenesis of K62, located on the edge of
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blade 1, weakens binding to the ribosome [79]. At least
four of these residues (K40, K87, R90, R102) are
expected to make direct contact with the sugar-phos-
phate backbone of the ribosomal RNA, forming salt
bridge interactions with the phosphates. Interestingly,
neither K62 nor K87 are fully conserved across RACK1
homologues, however, indicating some species differ-
ences in the interaction of RACK1 with the RNA of the
40S ribosomal subunit. Nevertheless, all the available
data from structural studies with eukaryotic ribosomes
points to a similar mode of engagement involving the
edge of blades 1 and 2 and accompanying loops on the
top face of the b-propeller. Interestingly, RACK1 associ-
ates with polysome bound polyA-mRNA enabling
PKCbII to phosphorylate polyA-mRNA-associated pro-
teins and control localized protein synthesis in neurons
[86].
RACK1 binding to the eukaryotic ribosome is not
purely mediated by interactions with the 18S RNA how-
ever. Additional contact occurs between RACK1 and co-
associated ribosomal proteins and, following the studies
described above, cryo-EM maps have emerged for ribo-
somes providing more detail for the assembled proteins
[87-89]. Very recently X-ray crystal structures have also
been obtained for complete eukaryotic ribosomal subu-
nits [80,83]. These studies have defined the interfaces
on RACK1 for co-association with three eukaryotic ribo-
somal proteins – rpS3e, rpS16e and rpS17e – as illu-
strated with the 40S subunit from T. thermophila at 3.9
Å resolution (Figure 9). The most extensive protein con-
tacts occur with a three-helix bundle formed by the N-
terminal region of rpS17e, which occupies one face of
the RACK1 propeller. The model suggests that a num-
ber of salt bridges are formed at the interface between
the two proteins, and these contacts involve the RDK
turn between strands B and C of blade 1 in RACK1.
Charge reversal mutations of the two basic residues in
this conserved turn had earlier been found to abrogate
binding of the yeast RACK1 ortholog (Asc1p) to the
ribosome (vide supra). The additional detail provided by
the crystal structure suggests that, whereas the Lys is
orientated towards phosphates on the nearby rRNA
backbone, the Arg of the RDK motif engages an Asp
residue (D27) on rpS17e. A phenylalanine side chain
(F30) on rpS17e, proximal to this Asp, inserts into the
mouth of the RACK1 tunnel to form extensive packing
interactions against aromatic side chains lining the inner
rim formed by the RACK1 D-A and B-C loops. Contact
between RACK1 and rpS16e is less extensive and
focused almost entirely on the edge of blade 1. The
third ribosomal protein, rpS3e, engages RACK1 with an
extended C-terminal strand that runs diagonally across
the edge of blade 4 and terminates in contact with the
C-D loop of blade 5. This strand is not defined in a
crystal structure for the yeast ribosome at 4.15 Å resolu-
tion and adopts a rather different trajectory across
blades 4 and 5 in a model derived from a cryo-EM map
of the ribosome at 6.1 Å resolution [83,89,90].
The ribosome binding mode for RACK1 established
through the recent cryo-EM and X-ray diffraction stu-
dies indicates that the top face of the RACK1 propeller,
as presented in Figure 2, is fully blocked when RACK1
is bound to the ribosome. In contrast, access to the
reverse face of RACK1 and several of the blade edges is
unobstructed, and these surfaces may serve as a plat-
form for recruitment of proteins to the ribosome. One
such protein known to be recruited to the translating
ribosome is PKCbII [91-93]. Competition experiments
with peptide sequences derived from WD-repeats 3 and
6 suggest that these regions of RACK1 contribute to the
PKCbII binding interface [92,93]. Significantly, both loci
are accessible in the established ribosome-bound
RACK1 structures. Thus, a mammalian RACK1
sequence (99-RRFVGHTKDV-108) corresponding to the
outer b-strand of blade 2 and D-A loop into blade 3 dis-
rupts association of RACK1 and PKC [92]. This
sequence, although located proximal to the rRNA of the
40S subunit (Figure 9), has significant surface exposure.
Remarkably, sequences from WD6 that are implicated
in PKC binding include both b-strands A (234-DII-
NALCF-241) and C (255-SIKIWD-260) of blade 6
[42-44,94-96]. Direct contact with residues in these
strands can only reasonably occur by intercalation of
structural elements from PKC between propeller blades
6 and 7 or, as has been proposed by others, [46]
through the peeling off of the outer strands in blade 6
to allow hybridisation with surrogate strands from PKC.
The sequence extension between blades 6 and 7 that
forms the RACK1 knob may be important in providing
flexibility for the structural transition required to
accommodate PKC by either of these modes. This knob
structure is bound close to rRNA and rp17e in the
established 40S structures, but mutagenesis and
sequence deletion studies indicate that it is not actually
essential for binding of RACK1 to the ribosome, at least
in the case of yeast [79]. Further work is required to
provide a detailed structural understanding of the inter-
action between PKC and RACK1 and this should
include consideration of the role of the RACK1 knob.
A very recent and exciting development in regards to
RACK1 structure has been the acquisition of an X-ray
crystal structure for the yeast protein, Asc1p, as a
homodimer [82]. This new structure has revealed a pre-
viously unprecedented mode of b-propeller dimerisation
involving blade hybridisation. Specifically, b-strands B
and C in blade 4 are extruded from the upper face of
the propeller as an extended loop for each of the proto-
mers in the dimeric assembly. The remaining strands (A
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Figure 9 Structure of RACK1 bound to the 40S eukaryotic ribosomal subunit and interaction with co-associated ribosomal proteins.
(A) Surface rendition of T. thermophila (PDB: 2XZN) 40S subunit: rRNA (white); RACK1 coloured as in Figure 2A/B; ribosomal proteins are shown
in grey with the exception of those in direct contact with RACK1 – rpS3e (light brown), rpS16e (light blue), rpS17e (pale cyan). (B) As (A) but
with 90° rotation about the y-axis; position of mRNA exit tunnel is marked (dashed oval). (C) Detail of ribosome-bound RACK1 structure,
highlighting PKC-binding loci on blades 2 and 6; RACK1 and rRNA are shown in ribbon format, interacting ribosomal proteins are surface-
rendered. (D) Detail of key contacts between RACK1 residues (italicised) and rpS17e residues (non-italicised): D27 (rpS17e) forms a salt bridge
with R47 (RACK1); F30 (rpS17e) packs against aromatic RACK1 side chains (W, Y, W, W). R47 (RACK1) engages rRNA backbone phosphates.
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and D) from blade 4 stay within the propeller core but
now hydrogen bond directly to one another. Thus, in
effect strand D migrates radially inwards to take the
position that the extruded strand B ordinarily occupies
in the monomeric protein. The two RACK1 protomers
then dimerise by hybridisation of the blade 4 D-strands,
forming a shared four-stranded antiparallel b-sheet in
the format, Protomer-A-D:D-A-Protomer. This mode of
dimerisation also brings the blade 3 edges of each proto-
mer sufficiently proximal to one another to hydrogen
bond, forming an extended eight-stranded b-sheet.
Remarkably, the extrusion-hybridisation mode of dimeri-
sation centred on blade 4 causes little perturbation in
the rest of the protein structure, and the protomers in
the dimeric assembly superimpose tightly onto the
structure of the monomeric RACK1 protein over the
blades not directly involved in dimerisation. The emer-
ging picture for the RACK1 homodimer provides impor-
tant new insights into the potential interactions between
RACK1 and its partner proteins. Firstly, it accounts for
the capacity of RACK1 to simultaneously scaffold the
NMDA receptor and Fyn (vide infra), where both of
these proteins target overlapping binding loci on
RACK1. Secondly, the model shows how buried
sequences within the core propeller blades may poten-
tially be exposed by extrusion to provide binding sur-
faces that are not exposed in the monomeric state. The
model is particularly significant in relation to the asso-
ciation of PKC (discussed above), where one model for
the interaction involves b-strand swapping between
RACK1 and the b-sandwich C2 domain of the kinase.
The RACK1 homodimer structure provides the first
direct evidence that such strand extrusion-insertion
mechanisms may indeed be important for the interac-
tion of RACK1 with its partners, and, if this is applicable
to the binding of PKCbII, that such mechanisms may
occur with blades other than blade 4 alone.
RACK1 and Signaling
RACK1 and PKC
As detailed above, RACK1 was first described as a
PKCbII anchoring protein [42], and has since been
extensively studied in relation to PKC signaling [46,97].
RACK1 binds activated PKCbII and the interaction
serves to stabilize the active conformation of the kinase
[42,45,60] (Figure 3). In addition, RACK1 serves as a
PKCbII shuttling protein, enabling the kinase to phos-
phorylate its substrate at the appropriate site [60] (Fig-
ure 2). Although most of the studies are focused on the
interaction of RACK1 with PKCbII isoform, several
other PKC isoforms bind RACK1 upon activation
[46,98,99]. In addition, the RACK1/PKC partnership was
suggested to be intrinsically linked and PKCs have been
shown to regulate RACK1 expression in cardiac
myocytes [100]. As well as stabilising PKC activity,
RACK1 introduces activated PKC to new signaling pro-
teins and pathways. These signaling proteins may be
directly scaffolded by RACK1 or RACK1 may shuttle its
cohort of bound PKC to particular cellular locations and
anchor a subset of activated PKC at specific receptor
sites. For example, RACK1 was shown to scaffold the
MAP kinase (MAPK), Jun N-terminal kinase (JNK) and
various PKC isoforms (abg) upon stimuli leading to
PKC phosphorylation of JNK [101]. Thus, RACK1 allows
the cross-talk between the PKC and MAPK pathways.
Recently, very exciting data published by the Lebel
group suggests that depletion of Werner syndrome,
RecQ helicase-like (WRN) protein in the nucleus causes
RACK1 to move out of the nucleus and to collocate
with PKCbII and PKCδ [102]. This suggests that PKC
may also function as a ‘sink’ for RACK1 in the cyto-
plasm, preventing RACK1 from going to the nucleus
non-specifically. The interaction between RACK1 and
PKC family members in the nucleus has also been
reported however. Specifically, RACK1 and PKCa are
recruited in a circadian manner into a nuclear brain and
muscle aryl hydrocarbon receptor nuclear translocator 1
(BMAL1) complex during the negative feedback phase
of the cycle [103]. This finding suggests that PKCa is
rhythmically activated during this process and that both
RACK1 and PKCa are an integral part of the oscillatory
mechanism. Finally, the interaction between RACK1 and
PKC isozymes plays a role in development [104], as dis-
cussed in section 5.1.
RACK1 and the cAMP/PKA pathway
The cAMP/PKA signaling pathway is also tightly linked
to RACK1 [29,56,105-107]. Specifically, cAMP is hydro-
lysed through the action of cAMP phosphodiesterases
(PDEs) [108], and RACK1 interacts with phosphodies-
terase isoform PDE4D5 [107,109,110]. Interestingly,
RACK1 and the scaffolding protein b-arrestin compete
for binding to PDE4D5 [109]. Furthermore, and as
detailed in section 5.2., RACK1 serves as the molecular
bridge linking the Focal Adhesion Kinase (FAK) to
PDE4D5 to control cell polarity [111,112]. In addition,
we previously reported that upon activation of PKA by
the adenylate cyclase forskolin, or the pituitary adenylate
cyclase activating peptide (PACAP), RACK1 translocates
to the nucleus where it mediates the expression of the
brain-derived neurotrophic factor (BDNF) [56,106] (Fig-
ure 4). Finally, the activation of the cAMP/PKA pathway
in hippocampal neurons also leads to the dissociation of
RACK1 from its binding partners Fyn kinase and the
NR2B subunit of the NMDAR, leading to the phosphor-
ylation of the subunit by Fyn, and to enhancement of
the channel’s activity [49,56] (Figure 5A) (see also sec-
tions 3.3 and 3.4.2).
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RACK1 and the Src family of non-receptor protein
tyrosine kinases
RACK1 plays an inhibitory role with the Src family of
non-receptor protein tyrosine kinases (PTKs), specifi-
cally with Src and Fyn. Thus, RACK1 interacts with Src
and Fyn respectively in cultured cancer cells and in neu-
rons, and this interaction inhibits the activity of the
kinases, suggesting that RACK1 plays an inhibitory role
on Src and Fyn kinase’s function [29,49,57,61,113,114].
Suppression of Src activity by RACK1 is central to the
regulation of the growth of colon cells [114] and a new
report suggests that by inhibiting Src activity, RACK1
stabilises E-cadherin and catenins at cell-cell contacts
[115]. The release of RACK1 from Src is mediated by
IGF-I [113], and the release of RACK1 from Fyn is
mediated by activation of the cAMP/PKA pathway [56],
resulting in the activation of both kinases (see also sec-
tions 5.3 and 6.2).
RACK1 and transmembrane receptors
RACK1 interacts with cytoplasmic tails of several recep-
tors including the Insulin-like Growth Factor Receptor I
(IGF-IR), b-integrin receptor, the common beta-chain of
the IL-5/IL-3/GM-CSF receptor [116], type I interferon
receptor [117], inositol 1,4,5-trisphosphate receptors
(IP3R) when at the cell membrane [118], the muscarinic
M2 receptor [119], the adiponectin receptor [120] the
androgen receptor [121], as well as several ion channels.
As described below, the interaction of RACK1 with
intracellular domains of transmembrane receptors
results in the positive or negative regulation of receptor
function.
RACK1 and receptor tyrosine kinases
One of the best studied receptor tyrosine kinase (RTK)/
RACK1 associations is the one between RACK1 and the
IGF-IR [76,77]. RACK1 interacts with the IGF-IR in a
wide variety of cells and the interaction site has been
mapped to the C-terminus of the IGF-IR. RACK1 also
interacts with the closely related Insulin receptor
[77,122]. At the IGF-IR, RACK1 recruits a series of pro-
teins including the adaptor proteins, Shc and IRS-1/2,
the phosphatase, Shp2, and the transcription factor,
STAT3 [77,113,122]. In doing so, RACK1 builds protein
complexes to facilitate signaling downstream of the IGF-
IR. RACK1 also binds the b subunits of integrin [123]
and integrates and facilitates signaling between the IGF-
IR and integrins during tumour cell migration
[76,77,124]. This is mediated in part by the serine/threo-
nine phosphatase PP2A as RACK1 binds PP2A and b1
integrin in a mutually exclusive manner [58,59]. In brid-
ging the IGF-IR and b1 integrin into one complex,
RACK1 facilitates the IGF-I and adhesion-mediated
recruitment of other proteins to the complex to
promote cell migration. Binding of RACK1 to integrins
also promotes the engagement of survival signaling
pathways [125], the MAPK pathway [126] and the
recruitment of several PKC isoforms [127-129].
RACK1 and ion channels
RACK1 is highly expressed in the CNS, mainly in neu-
rons, during development and also throughout the adult
brain, where it is localized to the neural cell bodies and
dendrites [71,86]. In the CNS, RACK1 interacts with the
cytoplasmic tail of ligand-gated and ion-gated channels
and plays an important role in the regulation of the
channels’ functions. Specifically, RACK1 binds the cyto-
plasmic domain of the b1 and b3 subunits of the
GABAA receptor (GABAAR) [96,130]. The interaction
between RACK1 and the GABAAR plays an important
role in facilitating the phosphorylation of the GABAARs
by PKCbII, thereby modulating GABAAR function in
response to the activation of muscarinic acetylcholine
and the serotonin receptors [96,130,131].
RACK1 also plays an important role in regulating the
function of the NMDAR. In the hippocampus and the
dorsal striatum, RACK1 interacts with the cytoplasmic
tail of the NR2B subunit of the NMDAR and simulta-
neously with the kinase, Fyn [49]. This simultaneous
interaction allows Fyn to be localized in close proximity
to its substrate, NR2B (Figure 5). However, as long as
RACK1 is present in the complex, Fyn cannot phos-
phorylate the subunit [49]. Activation of the cAMP/PKA
pathway leads to the dissociation of RACK1 from NR2B
and Fyn [29,56]. Once RACK1 is removed from the
NMDAR, Fyn is then free to phosphorylate NR2B,
which in turn results in an increase in the activity of the
channel [29,49,57] (Figure 5A). Interestingly, although
the three proteins are expressed throughout the brain,
the compartmentalization of Fyn to the NR2B subunit
of the NMDAR by RACK1 is detected in some brain
regions but not others. Specifically, the tri-molecular
complex is detected in the hippocampus and dorsal
striatum but is not found in the cerebral cortex or the
ventral striatum [49,55-57] (Figure 5B, C). Furthermore,
the compartmentalization of Fyn in close proximity to,
or away from, the NMDAR bears functional conse-
quences and provides the molecular mechanism under-
lying the difference in the sensitivity of the NMDAR to
alcohol in these brain regions [55,57] (see also section
6.2).
Finally, RACK1 has been pulled out in a yeast 2-
hybrid screen with the cytoplasmic tail of the large con-
ductance Ca2+ activated potassium (BK) channel [132].
RACK1 was shown to slow the activation of the channel
[132], although the functional experiments were con-
ducted in Xenopus Oocytes and must be confirmed in a
more physiologically relevant system. Nevertheless, this
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study serves as an example of the ability of RACK1 to
interact with ion-gated channels as well.
RACK1 and Examples of Other Interacting
Proteins
RACK1 and the Androgen Receptor
RACK1 has been shown to interact with the androgen
receptor (AR). In binding to the AR, RACK1 mediates
translocation of the receptor into the nucleus [121], and
also facilitates the cross-talk of the AR with other
kinases [133]. Specifically, the recruitment of Src to AR-
bound RACK1 facilitates the phosphorylation of the AR
on tyrosine residues and regulates its transcriptional
activity [133].
RACK1 and 14-3-3
Very recently, using a proteomics strategy, we identified
the scaffolding protein 14-3-3ζ as a binding partner of
RACK1 (Neasta et al. 14-3-3/RACK1, in revision). We
found that the interaction between the two scaffolding
proteins is direct and does not require the prior phos-
phorylation of RACK1 on consensus phospho-14-3-3ζ
binding sites. Using a RACK1-derived peptide array
approach, we identified two putative binding sites for
14-3-3ζ located within the WD2-3 and WD4-5 propeller
blade regions of RACK1. We found further evidence to
suggest that 14-3-3ζ is necessary for the shuttling of
RACK1 to the nucleus and to the subsequent activation
of BDNF transcription in response to activation of the
cAMP/PKA pathway (Neasta et al., 14-3-3/RACK1 in
revision). These findings provide the first intriguing
example that the interaction between two multifunc-
tional scaffolding proteins, RACK1 and 14-3-3ζ, can
provide a multiprotein signaling platform to tether
signalosome.
RACK1 and acetylcholinesterase
RACK1 interacts with the stress-induced splice variant
of acetylcholinesterase (AChE-R) ([134]. The interaction
between AChE-R and RACK1 leads to the recruitment
of PKCbII in the CA1 and CA3 regions of the hippo-
campus, as well as the basolateral amygdala [134].
Furthermore, peripheral anionic site (PAS) inhibition of
AChE in primary hippocampal neurons led to the redis-
tribution of RACK1, decreased Fyn expression and
NR2B insertion into the synaptic membrane, resulting
in spontaneous excitatory post-synaptic currents
(sEPSCs) [135].
RACK1, Postranslational Modifications and
Subcellular Compartmentalisation
Post-translational modifications
In response to stress, RACK1 is sequestered into stress
granules and inhibits apoptosis by suppressing stress-
responsive MAPK pathways [136] Elegent studies car-
ried out by Ohn et al, [137], have revealed that in
response to arsenite-induced stress, RACK1 is reversibly
modified by O-linked N-acetylglucosamine (O-GlcNAc)
and moves from polysome-containing fractions to
monosome-containing fractions of the cell. This study
also indicates that when modified by O-GlcNAc,
RACK1 moves to ribosomal subunit-containing fractions
where it associates with the translational machinery and
promotes stress granule assembly. Little is known about
other post-translational modifications of RACK1 apart
from phosphorylation which is emerging as an impor-
tant factor that modulates the binding of proteins to
RACK1. RACK1’s sequence contains six tyrosine resi-
dues: Tyr-52 (located at the boundary of WD1 and
WD2), Tyr-140 (WD 4), Tyr-194 (WD5), Tyr-228 and
Tyr-246 (WD 6), and Tyr-302 (WD7). Phosphorylation
of RACK1 on Tyr-52 by c-Abl mediates the interaction
with FAK [124], which is required for cell adhesion and
cell migration while phosphorylation/dephosphorylation
of Tyr-302 in WD7 of RACK1 regulates the mutually
exclusive association of RACK1 with PP2A and b1
Integrin [58,59]. Phosphorylation of RACK1 on Tyr-246
is required for the binding of Src kinase to RACK1
[138]. The interaction between RACK1 and Src is essen-
tial for the regulation of Src activity during the cell
cycle [114,139]. RACK1 is also a substrate of Src. Speci-
fically, Src phosphorylates RACK1 on Tyr-228 and
strong evidence suggests that Src phosphorylates
RACK1 on Tyr 246 also [48]. In addition, serine phos-
phorylation of RACK1 is also reported. Phosphorylation
of RACK1 on Ser-146 promotes its dimerization which
is required for the degradation of HIF-1a [140]. Taken
together, these studies suggest that RACK1 is modified
by signaling pathways which is important for protein
binding and RACK1 location.
Subcellular localization and translocation
RACK1 immunoreactivity can be detected in various
cellular compartments including the cytosol, endoplas-
mic reticulum and the nucleus. In neurons, RACK1 is
detected in cell bodies and dendrites but not in axons
[71,86]. In addition, translocation of RACK1 from one
subcellular location to another has been shown to med-
iate various cellular responses following a stimulus. For
example, in response to PKC activation, RACK1 accom-
panies PKCbII to its site of action [60] (Figure 2), and
as mentioned above, upon cellular stress induced by
hypoxia or heat shock, RACK1 is sequestered into cyto-
plasmic stress granules preventing the activation of a
stress-responsive MAPK pathway, which in turn leads to
cell survival instead of cell apoptosis [136]. Moreover,
the activation of the cAMP/PKA pathway in various
types of cells, including neurons, induces RACK1
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translocation to the nucleus [56,106,141,142] subse-
quently leading to the transcription of the brain-derived
neurotrophic factor (BDNF) [56,57,106,143] and (Neasta
et al 14-3-3/RACK1 in Revision) (Figure 4). The RACK1
sequence does not contain known organelle localization
motifs, or N-terminal lipid modification sites; nor does
the sequence contain nuclear entry or nuclear export
signals. In addition, there are no conclusive reports that
the subcellular location of RACK1 is controlled by post-
translational modification of RACK1 itself. Thus, the
movement of RACK1 around the cell is most likely
influenced by the particular cohort of proteins asso-
ciated with RACK1 at any one time. An example, of
such interacting protein is 14-3-3 which enables RACK1
to be transported to the nucleus in response to the acti-
vation of the cAMP/PKA pathway (Neasta et al 14-3-3/
RACK1 in Revision).
RACK1 in the nucleus
As detailed above, activation of the cAMP pathway in
various types of cells, including neurons induces RACK1
translocation to the nucleus, subsequently leading to the
transcription of several genes including BDNF
[56,106,141,143] and (Neasta et al 14-3-3/RACK1 in
Revision). In relation to BDNF transcription, using ade-
novirus-mediated siRNA delivery to knockdown the
level of RACK1 in differentiated SHSY5Y cells and hip-
pocampal neurons, we showed that activation of the
cAMP pathway results in the association of RACK1 with
the promoter IV region of the BDNF gene, leading to an
increase in exon IV specific BDNF transcription [106].
RACK1 has been identified in several other complexes
in the nucleus. It binds to the RQC domain and the
acidic region of WRN and WRN may play an important
role in retaining RACK1 in the nucleus [102]. Ki-1/57, a
Ser/Thr protein kinase that interacts with chromo-heli-
case DNA-binding domain protein 3, forms a tight com-
plex with RACK1 in the nucleus and treatment of cells
with the PKC activator, PMA, mediates threonine phos-
phorylation of Ki-1/57 and disrupts the interaction with
RACK1 [144]. Finally, RACK1 is also an essential com-
ponent of systems required for regulating HIF-1a stabi-
lity [54,145] and it does so by competing with HSP90
for binding to HIF-1a.
RACK1 and ribosomes
An exciting development in RACK1 physiology is the
realisation that RACK1 has a key role to play in the
translation machinery [146]. The identification of
RACK1 as a ribosome-associated protein was first made
by mass spectroscopy [147], and in recent years RACK1
has become a well-established component of the riboso-
mal machinery through studies with ribosomes from
yeast [83,84,89,148-151] and fungi [88], from unicellular
algae [152] and plants [89,90,153-156] from protozoa
[80] and mammals [85,86,137]. As discussed (Part 2),
the RACK1 binding site, located on the 40S subunit of
the eukaryotic ribosome, is now well defined by several
structural studies.
Although ribosome-bound RACK1 might directly regu-
late translation per se, its function as a ribosomal protein
is likely linked to its capacity to recruit a particular
cohort of RACK1-associated proteins such as activated
PKCbII. Indeed, PKC-mediated translational control has
recently been shown to be dependent upon RACK1, and
a RACK1-derived peptide that disrupts PKCbII binding
to RACK1 or down-regulation of RACK1 with siRNA
impairs PKC-stimulated translation [92]. The action of
PKCbII in stimulating translation is thought to arise, at
least in part, from its phosphorylation of eukaryotic
initiation factor 6 (eIF6) bound to the 60S ribosomal sub-
unit. Specifically, assembly of the ribosome by joining of
40S and 60S subunits is a rate-limiting step in translation,
and PKCbII-mediated phosphorylation of a carboxy
terminal serine (S235) in eIF6 triggers release of the
initiation factor to facilitate this [91]. Identification of the
ribosomal binding site for RACK1 has therefore sug-
gested a model for ribosome assembly in which phos-
phorylation of eIF6 by PKC occurs on the 60S subunit as
a result of an interaction with eIF6 and PKC bound to a
nearby 40S subunit via RACK1 [84]. RACK1 is also
known to bind eIF6 directly, although the loci on RACK1
for this interaction have not yet been defined and it is
unclear whether phosphorylation of eIF6 by PKC involves
simultaneous association of both enzyme and substrate
initiation factor on the ribosome-bound RACK1.
In contrast to its role in promoting translation, other
studies suggest that RACK1 may act at the ribosome to
repress gene expression [148,157]. Specifically, very
recently it has been shown that RACK1 interacts with
components of the microRNA-induced gene silencing
complex, contributing to recruitment of the complex to
the site of translation and suggesting that RACK1 facili-
tates a post-initiation mode of miRNA-mediated gene
repression [157]. RACK1 may also be involved in trans-
lation arrest, and its binding at the 40S subunit has
been shown to be essential for nascent polypeptide-
dependent translation arrest [158]. Finally, it is also fea-
sible that the action of RACK1 at the ribosome may
result in varying effects on gene expression by recruiting
proteins that regulate translation of specific mRNAs in
different ways. For example, Baum et al. suggested that
recruitment of the mRNA-binding protein, Scp160p, to
the yeast homolog (Asc1p) of RACK1 may influence the
translation of specific mRNAs [159]. In addition to
affecting the rate of translation of mRNAs, RACK1 is
thought to play a role in influencing the location of
translation, for example, in neurones [86].
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RACK1 and Physiological Functions
RACK1 and development
In recent years, a critical role for RACK1 in develop-
ment has been emerging. For example, in zebrafish,
RACK1 affects membrane localization of van gogh-like
2 (Vangl2), and the Vangl2-interacting region of RACK1
has been shown to exert a dominant-negative effect on
Vangl2 localization and gastrulation [160]. The interac-
tion between RACK1 and tyrosine-protein kinase-like 7
(PTK7) has also been shown to be a requirement for
neural tube closure in Xenopus [161]. In Arabidopsis,
where three RACK1 homologs are present, the RACK1
gene products are essential regulators of plant develop-
ment [162,163]. RACK1 homologs in Drosophilia [164],
Aspergillus nidulans [165], Schizosaccharomyces pombe
[166] and Trypanosoma brucei [167] have similarly been
shown to be central to various stages of the develop-
mental process.
RACK1 and circadian rhythm
Recent elegant studies by Robles et al. [103] have identi-
fied RACK1 as an integral component of the mamma-
lian circadian clock. Their findings suggest that RACK1
and PKCa regulate CLOCK-BMAL1 transcriptional
activity [103]. Their findings also indicate that the
mechanism of action of RACK1 and PKCa are intrinsi-
cally linked and that the function of one is dependent
on the other. Although it is well established that
RACK1 regulates PKC location [60,92,134,142], this
exciting development in RACK1 biology reveals a novel
mechanism of action.
RACK1 and cell migration
The scaffolding of signaling proteins by RACK1 at
receptors is particularly important in dynamic processes
such as cell migration, cell adhesion and cell spreading
[76,77,113,124]. All of these processes require the highly
regulated converging of transient signaling between
receptors. For example, RACK1 was first found to be a
mediator of cell spreading by establishing contact with
the extracellular matrix and growth factor receptors at
adhesion sites [76].
The role of RACK1 as a scaffolding protein is clearly
evident during cell migration. Cell migration is a funda-
mental process required for embryonic development,
wound healing and immune responses, and the compo-
nents of cell migration are functionally conserved in
evolution. The failure of cells to migrate, or indeed their
migration to the wrong location, gives rise to serious life
threatening consequences such as defective brain devel-
opment, a malfunctioning immune system and leads to
the materialization of cancer. Understanding cell migra-
tion presents a considerable challenge because it results
from the coordinated activity of several individual intra-
and extracellular component processes. These processes
include several signaling pathways, and require signifi-
cant and well-orchestrated cross-talk between cell sur-
face receptors and elements of the cell cytoskeleton.
RACK1 is essential for cell migration, and the protein
binds to many components of the cell migration
machinery including kinases, phosphatases and the cyto-
plasmic domains of cell surface receptors [46,47].
RACK1 is located in areas of cell protrusion that are
rich in paxillin [168,169] and can increase the phosphor-
ylation of FAK [169]. The interaction of RACK1 with b1
and b2 integrins and Src regulates cell adhesion and cell
spreading [123,168]. RACK1 has been reported to bind
to components of the cell cytoskeleton [128,170]. The
identification of proteins such as these as RACK1 part-
ners has led to the establishment of RACK1 as a key
regulator of Focal Adhesion assembly (Figure 10). Focal
adhesions are large dynamic macromolecular assemblies
with both mechanical components and cell signaling
components [171-175]. Specifically, focal adhesions are
the mechanical link between the cell and the extra cellu-
lar matrix (ECM), that are formed after integrins are
clustered on the cell surface. Integrin clustering is suffi-
cient to promote the phosphorylation of FAK on Tyr-
397. This in turn generates a binding site for the Src
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Figure 10 RACK1 is an important regulator of Focal Adhesion
assembly. When a cell is in contact with the Extracellular Matrix,
integrins are clustered on the cell surface. This clustering of
integrins leads to the recruitment of FAK and to the establishment
of focal adhesions. At focal adhesions, RACK1 recruits key structural
proteins, kinases and phosphatases to help nurture the developing
focal adhesion. It is likely that at focal adhesions RACK1 brings in
phosphodiesterases and ribosomes which facilitate local signaling
and translation. A change in RACK1 expression (both up and down)
has consequences for the activity and stability of RACK1-associated
proteins and is believed to be a contributing factor in the
development and progression of cancer.
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homology 2 (SH2) domain of Src Family protein tyro-
sine kinases (Src-family PTKs). The recruitment of Src-
family PTKs to FAK is dependent on the initial autop-
hosphorylation of Tyr-397 and results in the phosphory-
lation of FAK at secondary sites to ensure full activation
of FAK. This correlates with an increase in kinase activ-
ity and the ability of FAK to cooperate with multiple
signaling pathways through its direct interaction with
other non-receptor tyrosine kinases, cell surface recep-
tors, cytoskeletal proteins and other adaptor proteins.
FAK is widely regarded as being the convergence point
of growth factor and integrin signaling [176,177], yet
how FAK phosphorylation is regulated within the
growth factor and integrin network is not fully under-
stood. Nevertheless, the phosphorylation status of FAK
clearly regulates cell adhesion and cell migration in
response to growth factors, integrin stimulation and
components of the extracellular matrix. RACK1 is
essential for FAK’s function as it scaffolds the kinase for
activation by both IGF-I and adhesion signals [124] and
the binding locus for FAK on RACK1 has been mapped
to Tyr-52 in WD2 of RACK1 [124] and the interaction
site of RACK1 on FAK was subsequently identified
[112]. Suppression of RACK1 expression disrupts FAK
activity, cell adhesion and cell spreading [113,124,169],
two essential steps in the cell migration process, by the
interaction of RACK1 with FAK and by the ability of
RACK1 to regulate FAK activity. In addition, recent stu-
dies suggest that attenuation of RACK1 expression sup-
presses VEGF-mediated cell migration by disrupting the
path between VEGF, the PI3K pathway and Rac1 [178].
RACK1 (and RACK1A) is known to interact with several
components of the Rac1 complex that are involved in
cell migration [179,180]. Cell migration is dependent on
the response to chemoattractant gradients, and in Jurkat
cells RACK1 interacts with Gbg at the leading edge of
cells [181]. In this system, RACK1 inhibits cell migration
and overexpression of full length RACK1 or truncation
mutations that retain the Gbg binding, actually inhibit
cell migration [181]. There are other reports suggesting
that RACK1 inhibits cell migration [128] but under
most circumstances, RACK1 facilitates cell migration. A
large part of what RACK1 does in cell migration, at
least in adherent cells, is mediated by its ability to bind
to a series of kinases and phosphatases that affect the
phosphorylation and subsequent activity of other
RACK1 binding partners or proteins in complexes
where RACK1 is found. RACK1 interacts with several
PKC isoforms during cell migration including PKCb
[170] and PKCε [127]. Activation of the PKC signaling
pathway also enhances the interaction between RACK1
and Src [138]. Src tyrosine kinase phosphorylates
RACK1 and phosphorylation of RACK1 is required for
Src binding to RACK1 via its SH2 domain [48]. Src is a
well-known regulator of cell adhesion, cell spreading
and cell migration [61,62,114,168]. Src activity is inhib-
ited by the binding of RACK1 but RACK1 can transport
Src to specific cellular compartments where Src can
function. In fibroblasts and epithelial cells, the interac-
tion between RACK1 and Src is disrupted by IGF-I sti-
mulation of the IGF-IR signaling pathway [113]. This
results in the release of now active Src at a specific loca-
tion and is an example of how RACK1 can regulate the
local activation of proteins. The regulation of Src activ-
ity by RACK1 is also required for modulating paxillin
during cell migration [182], for regulating Sam68 and
p190RhoGAP signaling [183], to control cell protrusion
during cell migration [168] and for regulating cell cycle
checkpoints [62,114,139]. The dynamic interaction
between RACK1 and Src is also required for regulation
of the phosphorylation and function of the Androgen
receptor [133]. There are now data suggesting that the
interaction between RACK1 and Src goes beyond regu-
lating cell adhesion and cell migration and Mamidipudi
et al, have shown that the interaction has a pro-apopto-
tic function [184]. The interaction of RACK1 with phos-
phatases during cell adhesion is equally important and
mounting evidence suggests that RACK1 receives signals
to recruit phosphatases that dismantle specific signaling
pathways and cytoplasmic support systems such as focal
adhesions [58,124,185]. In IGF-IR signaling, RACK1
promotes IGF-I-mediated cell migration by regulating
the formation of a RACK1-IGF-IR and b1 integrin com-
plexes, which is mediated by the mutually exclusive
association of RACK1 with PP2A and b1 integrin
[58,59]. In pancreatic cells, RACK1 and PP2A form a
complex with IRE1a in a signaling pathway that regu-
lates insulin production [186]. In addition, RACK1 and
phosphatases are involved in cell migration in other sys-
tems. Fo example, in the retina, retinal ganglion cell
axons are guided by signaling pathways that are regu-
lated by an interaction between RACK1 and PTP μ
[185,187-189].
RACK1 in Disease
Since its discovery, RACK1 has been associated with
various aspects of diseases. Alterations in RACK1 home-
ostasis is associated with brain developmental disorders
[161], heart failure [99], pulmonary arterial hypertension
[190], renal failure [191], muscle atrophy [192] and dys-
functional sperm development [193], as well as cancer
and addiction (detailed in sections 6.1 and 6.2). In addi-
tion, altered RACK1 expression has negative conse-
quences for the properties and activity of RACK1
binding partners. The association of RACK1, PKCbII
and a variant of the acetylcholinesterase AChE has been
implicated in stress-induced behaviors [134] (see also
section 6.2). Increased RACK1 expression has also been
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observed in the frontal cortex of patients with bipolar
disorder [194], while decreased RACK1 expression is
reported in the cortex of Down syndrome patients [74].
In addition, RACK1 levels are significantly reduced in
aged rats [195], and decreased RACK1 expression is
reported in post-mortem brains of Alzheimer’s disease
(AD) patients [72,73]. However these changes were not
found in another study, which compared the levels of
RACK1 in AD patients and age-matched controls [196].
Nevertheless, the pathophysiology of AD patients also
highlights defective PKC activity and localisation which
correlates with decreased RACK1 expression [197]. PKC
and muscarinic receptor signaling are intrinsically
linked, and amyloid-b impairs the regulation of PKC
and GABAergic signaling. Overexpression of RACK1
has been shown to restore the regulation of these pro-
cesses [198].
Several reports suggest a role for RACK1 in the
immune system. Specifically, studies carried out in T
Jurkat cells indicate that RACK1 regulates directional
cell migration [181] while other reports suggest that
RACK1 regulates T cell apoptosis [199]. In Rice,
RACK1A functions in innate immunity by interacting
with the GTP form of Rac1 [179] and having a central
role in the production of reactive oxygen species in
response to infection. Because of its role in several sig-
naling pathways, it is not surprising, therefore, that
RACK1 is hijacked by viruses to facilitate viral replica-
tion [200-202].
RACK1 and cancer
Many reports indicate that RACK1 plays an important
role in cancer progression and that its expression is
altered during angiogenesis and in many human carci-
nomas. Specifically, RACK1 expression is being assessed
as a prognostic indicator in breast cancer [203,204],
where increased RACK1 expression is strongly related
to advanced clinical stage [205]. In pulmonary adenocar-
cinomas, increased RACK1 expression is associated with
pathological stage and tumor size and is also a potential
diagnostic marker [206]. In contrast, some reports sug-
gest that RACK1 expression is reduced in breast cancer
[207]. In addition, RACK1 may protect cells from apop-
tosis in breast cancer [204,208]. RACK1 is upregulated
in hepatocellular carcinoma where it increases the trans-
location of A Disintegrin And Metalloprotease 12
(ADAM12) to the plasma membrane in response to
PKC activation [209] and it is upregulated in metastatic
melanoma, where it amplifies PKCa and PKCb activity
[210]. In melanoma, constitutive activation of the MEK-
ERK signaling pathway leads to elevated c-Jun activity
and increased the transcription of RACK1 [211]. RACK1
is also implicated as a key player in ovarian cancer
[212], prostate cancer [188] and in cancers caused by
pathogens such as human papillomavirus 16 (HPV 16)
[213] and Helicobacter pylori [214].
There are several mechanisms by which RACK1 con-
tributes to the progression of cancer. Firstly, RACK1 is
upregulated during angiogenesis [215] where it pro-
motes activation of the PI3K/Akt/Rac1 pathway [178]
and regulates HIF-1 transcriptional activity [216,217].
RACK1 also plays an important role in cell proliferation,
cell adhesion and cell migration, which are all essential
components of transformation as described in section
5.3. The interaction between RACK1 and FAK is consti-
tutive and FAK phosphorylation on the RACK1 scaffold
is mediated by the IGF-IR [124]. The interaction
between RACK1 and FAK is found at nascent adhesions
and is required at the leading edge of polarized cancer
cells to sense direction. RACK1 also brings FAK and
PDE4D5 together which strongly suggests that adhesion
signaling and cAMP signaling are linked in cancer
[111,112]. At adhesion sites, RACK1 recruits paxillin
[168,169], integrins and Src to regulate cell adhesion
and cell spreading [113,123,124,168], b-tubulin [218]
and other components of the cell cytoskeleton [170].
Thus, in cancer, RACK1 becomes a focal point for
transformation signaling (Figure 10). RACK1 recruits
ribosomes and PKC (discussed above) and scaffolds cen-
tral components of the MAPK pathway [126] and the
PI3K pathway [76,77,113]. As well as this, RACK1 scaf-
folds a host of other different kinases and phosphatases,
and the activity of several of these proteins is altered in
cancer. All of these proteins, signaling pathways and
protein complexes require tight regulation. Subtle
changes in the protein expression (both up and down)
of a fundamental protein such as RACK1 can be
expected to have dramatic consequences on the regula-
tion of these key pathways and therefore on the devel-
opment and progression of neoplastic disease.
RACK1 and addiction
Addiction is a costly, devastating psychiatric disorder.
The disease manifests itself in the intake of the drug
regardless of the negative consequences, and is asso-
ciated with tolerance, dependence, withdrawal, relapse
and craving [219]. Altered levels and compartmentaliza-
tion of RACK1 was reported by us and others to be
linked to exposure to drugs of abuse. Specifically,
changes in RACK1 levels have also been described in
response to the treatment of rodents acutely and chroni-
cally with morphine. Escriba et al. found that acute
treatment of rats with morphine results in increased
RACK1 levels in the frontal cortex, whereas chronic
treatment with morphine led to a decrease in the level
of RACK1 in this brain region [220]. The authors also
report that changes in RACK1 levels paralleled with
changes in the levels of PKCa and PKCb [220]. In
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contrast, Wan et al. found that chronic treatment of
mice with morphine led to an increase in the level of
RACK1 in this brain region [221]. Finally, Liu et al.
reported that alteration of RACK1 levels result in
changes in the rewarding properties of morphine
[222,223]. In summary, although changes in RACK1
expression are linked to morphine administration,
further studies are needed before any conclusions can
be drawn.
In addition, over the past several years, we have
demonstrated that one of the molecular mechanisms by
which alcohol can simultaneously alter several signaling
pathways is by altering the cellular compartmentaliza-
tion of RACK1. Furthermore, we obtained data to sug-
gest that the functional outcomes of the altered
localization of RACK1 in the presence of alcohol are
diverse, as RACK1 contributes both to mechanisms that
underlie but also those that prevent the escalation of
behaviors that underlie alcohol addiction. The interest
in the potential role of RACK1 in alcohol addiction was
initiated with the observation that exposure of several
cell lines as well as primary neurons to alcohol results
in a dose- and time-dependent translocation of RACK1
to the nucleus [141-143,224]. The nuclear translocation
of RACK1 in response to alcohol was shown to be
dependent on the activation of the cAMP/PKA pathway
[141]. Interestingly, prolonged incubation of cells with
alcohol (12-48 hrs) results in the gradual distribution of
RACK1 out of the nucleus, which was resistant to an
acute challenge of alcohol [143,224]. These results sug-
gest a cellular alcohol tolerance leads to altered com-
partmentalization of RACK1. Furthermore, as a result of
the nuclear localization of RACK1 in response to acute
alcohol exposure, the translocation of active PKCbII is
inhibited [142], and the transcription of several genes
are induced [141-143,224].
Of great interest is the observation that the expression
of the growth factor BDNF is increased in response to
alcohol-mediated RACK1 nuclear localization [143].
Importantly, molecular and behavioral studies suggest
that RACK1 and BDNF are part of an endogenous
homeostatic pathway that delays or prevents the devel-
opment of alcohol addiction. Specifically, acute increase
of RACK1 protein levels in hippocampal and striatal
neurons using the Tat protein transduction approach
(Tat-RACK1), led to increases in the levels of BDNF
and a similar increase in BDNF expression was observed
after systemic injection of the Tat-fusion protein in
mice [143]. The systemic administration of mice with
Tat-RACK1 resulted in a robust decrease in alcohol but
not water consumption in mice in a BDNF-dependent
manner [143,225]. Specifically, the activity of Tat-
RACK1 on alcohol consumption was reduced in BDNF
heterozygote mice as compared to wild-type mice, and,
systemic administration of a BDNF receptor TrkB inhi-
bitor increased alcohol consumption in wild-type con-
trols, but not in BDNF heterozygote mice [143,225]. We
also provide data that the inhibitory actions of RACK1
on alcohol intake are localized to the dorsal striatum as
infusion of Tat-RACK1 directly into the dorsal striatum
of rats reduced rat operant self-administration of alcohol
[225]. Finally, we obtained data to suggest that the con-
sequence of RACK1 mediated increase in BDNF expres-
sion in response to alcohol is the increase in the
expression of the dopamine D3 receptor and Dynorphin
which in turn mediate the reduction in the sensitivity of
rodents to alcohol [225,226]. Together, these results
suggest that RACK1 inhibits alcohol consumption by
increasing the expression and secretion of BDNF, and
that secreted BDNF counteracts the reinforcing or
rewarding effects of alcohol. Thus, the RACK1 and
BDNF pathway contributes to cellular and molecular
processes that influence the motivation to seek alcohol.
Interestingly, the altered compartmentalization of
RACK1 in response to alcohol exposure in specific brain
regions also contributes to neuroadaptations that under-
lie the development of alcohol addiction. As described in
section 1.2, in the hippocampus and the dorsal striatum
but not in the cerebral cortex or ventral striatum,
RACK1 localizes Fyn in close proximity to the NR2B sub-
unit of the NMDAR, but inhibits the ability of Fyn to
phosphorylate the channel until the appropriate signal
occurs [29,49,55,57,141] (Figure 5A). This specific com-
partmentalization of Fyn to the NMDAR complex via
RACK1 has broad implications for the actions of alcohol
on the channel. In the hippocampus, alcohol treatment
results in the release of RACK1 from the NMDAR com-
plex in a mechanism that depends on the activation of
the cAMP/PKA signaling cascade [57]. The dissociation
of the tri-molecular complex in response to alcohol
enables Fyn to phosphorylate NR2B [57]. These molecu-
lar changes in the hippocampus lead to a reduction in
the inhibitory actions of alcohol on channel activity, in
rebound potentiation of the activity of the channel when
alcohol is washed out, and to the development of acute
desensitization to the inhibitory actions of alcohol on the
activity of the channel [57]. In the dorsal striatum,
RACK1 dissociation from Fyn and NR2B and the phos-
phorylation of the subunit by Fyn leads to long-lasting
long-term facilitation of the activity of the channel [55].
Importantly, this biochemical neuroadaptation in the
dorsal striatum is part of a mechanism that underlies
excessive alcohol consumption and relapse [55,227].
In summary, the altered compartmentalization of
RACK1 in the presence of alcohol in specific brain
regions results in diverse physiological consequences
that both contribute to, and prevent, the development of
behaviors associated with alcohol addiction.
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Summary and Future Perspectives
Since its identification as an anchoring protein for active
bIIPKC [42], the number of binding partners and func-
tions for RACK1 have increased exponentially. It is
intriguing that a single protein can be involved in such
a large number of diverse biological functions. One pos-
sibility is that the different intracellular compartmentali-
zation of RACK1 in different cell types and regions
allows the scaffolding protein to interact with multiple
proteins and to regulate various functions in a cell spe-
cific manner (see Figure 10 as an example). Another
possibility to explain the multiple functions of RACK1 is
that although the protein itself is ubiquitously expressed,
its binding partners are not. For example, RACK1 is ubi-
quitously expressed in the adult mouse brain, however, a
much more restricted expression pattern is observed for
PKCbII [71,228]. Interestingly, as described above,
RACK1 can be associated with different binding part-
ners in different brain regions. Specifically, although
similar type of neurons are found in the hippocampus
and cortex as well as in the ventral and dorsal striatum,
RACK1 is associated the NR2B subunit of the NMDAR
in the hippocampus and the dorsal striatum, [49,55-57]
but not cerebral cortex but not in the ventral striatum
[55,57]. These findings suggest that RACK1 scaffolds
different proteins in these brain regions. The reasons for
cell type or brain region specificity of RACK1 associa-
tion with its binding partner is unclear and therefore it
would be of great interest to explore this further.
Furthermore, we now know that proteins, such as
PP2A and b1 integrin, compete for binding to RACK1
[58,59], and that phosphorylation of RACK1 on tyrosine
and serine residues is critical for the way in which
RACK1 functions during cell adhesion and cell migra-
tion [61,114,124]. It is thus essential that we gain a bet-
ter understanding of what determines the hierarchy of
protein binding to RACK1 and what signals orchestrate
complex formation on RACK1. For example, growth
factor and adhesion signaling converge on RACK1
[76,113,122,124], but it of interest to now focus on how
other external environmental cues dictate the binding
profile and cellular distribution of RACK1 and how
RACK1 integrates these signals with such a high degree
of specificity and regulation.
Finally, the unique structure of RACK1 and the expan-
sion of knowledge of the protein-protein interactions
mediating the binding of RACK1 to partners provide us
with a great opportunity to develop new therapeutics by
the design and development of peptides, and in the future
possibly small organic compounds, which will interfere
with specific binding of proteins to RACK1. This will
permit subtle manipulation of the activity of specific
enzymes, receptors and signaling pathways.
Endnotes
Footnote 1
1A convenient graphical representation of consensus
residues at particular sites within WD-repeats has been
given by Xu and Min [6]. Significant diversity is seen
across repeats in WD40 proteins and we refer to ‘typical’
repeats as ones that preserve the core interactions sum-
marised in Figure 7.
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